Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
Zinc combination therapy shows slight trend toward survival benefit in alcoholic hepatitis
SAN FRANCISCO — Combination therapy with Kineret, Trental and zinc sulfate showed only a slight trend toward 90-day improved survival in patients with alcoholic hepatitis but otherwise showed little benefit, according to data presented at The Liver Meeting 2018.
DAAs reduce HCC, decompensation risk compared with no treatment
SAN FRANCISCO — Individuals with hepatitis C who underwent DAA therapy experienced significant reductions in both hepatocellular carcinoma and decompensation risk compared with untreated patients, according to data presented at The Liver Meeting 2018.
Log in or Sign up for Free to view tailored content for your specialty!
Alcohol relapse score predicts early liver transplant eligibility
SAN FRANCISCO — A novel prognostic score using four objective pretransplant variables identified patients with alcoholic hepatitis who were candidates for early liver transplantation with a low risk for sustained alcohol use posttransplant, according to data presented at The Liver Meeting 2018.
HCV telemedicine program satisfying, cost-effective in Spanish prison
SAN FRANCISCO — A telemedicine program brought high levels of satisfaction and proved cost effective in patients with hepatitis C in a Spanish prison, according to data presented at The Liver Meeting 2018.
Universal screening for HCV superior to risk-based approach in pregnant women
SAN FRANCISCO — Universal screening of pregnant women at risk for hepatitis C was more efficient and cost-effective compared with risk-based screening, according to data presented at The Liver Meeting 2018.
Healio to report live from The Liver Meeting 2018
SAN FRANCISCO — Starting this weekend, Healio Gastroenterology and Liver Disease will provide live coverage from The Liver Meeting 2018.
FDA approves Dsuvia for acute pain management
Today, the FDA announced the approval of Dsuvia for the management of acute pain in adults that is severe enough to require an opioid analgesic in medically supervised settings, according to a press release.
FDA allows for expanded marketing of 23andMe to include medication metabolism
The FDA expanded the approved marketing of the 23andMe Personal Genome Service Pharmacogenetic Reports test to include information about 33 genetic variants that may be linked with a patient’s ability to metabolize some medications to help inform discussions with a health care provider, according to an agency press release.
ACP issues new recommendations to reduce gun violence
ACP updated its policy recommendations for reducing gun-related injuries and deaths in the United States by building on, strengthening and expanding on current policies, according to a position paper published in Annals of Internal Medicine.
AMA announces new initiative supporting ‘meaningful improvements’ to residency training
AMA recently announced that it will award $15 million in grant funding over the next 5 years to training programs that discuss the changing needs of patients, communities and the workforce needs of the current and future health care system.
-
Headline News
Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?
September 27, 20245 min read -
Headline News
Prenatal cannabis use in California nearly doubled amid legalization from 2012 to 2022
September 26, 20242 min read -
Headline News
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
September 26, 20242 min read
-
Headline News
Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?
September 27, 20245 min read -
Headline News
Prenatal cannabis use in California nearly doubled amid legalization from 2012 to 2022
September 26, 20242 min read -
Headline News
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
September 26, 20242 min read